ArticleFrontiers in endocrinology2025
Progesterone decline threshold in predicting early pregnancy loss: a retrospective study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of the Salivary Progesterone-to-Estradiol Ratio with Threatened Miscarriage.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The single measurement of serum progesterone is considered a predictor for non-viable pregnancies. However, the dynamic change in progesterone during early pregnancy loss (EPL) remains uninvestigated. This study evaluated the association between serum progesterone decline thresholds (PDT) and EPL. Methods: This retrospective study included 664 pregnant women who visited a single medical center from January 2023 to December 2024. Based on pregnancy outcomes within the first trimester, participants were classified into the ongoing pregnancy group (n=388) and the EPL group (n=286). PDT was defined as a decline of ≥ 1/5 standard deviation (SD), 1/3 SD, 1/2 SD, 7/10 SD, or 1 SD compared with the last measurement of serum progesterone levels. SD was calculated based on the baseline serum progesterone levels. Multivariate logistic regression was applied to explore the association between PDT and EPL. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic value of PDT. Subgroup analyses were performed to evaluate the robustness of the results. Results: Compared with the ongoing pregnancy group, the EPL group had significantly lower baseline serum progesterone levels (P < 0.05). PDT ≥ 1/5 SD, 1/3 SD, and 1/2 SD were all significantly associated with EPL (OR [95%CI]=2.74 [1.76, 4.27], P < 0.001; OR [95%CI]=1.74 [1.18, 2.56], P=0.005; and OR [95%CI]=1.63 [1.07, 2.49], P=0.024, respectively). The corresponding AUC values were 0.502, 0.512, and 0.503. Additionally, a linear positive correlation was observed between the number of occurrences of PDT ≥ 1/3 SD and EPL. For each additional occurrence of PDT ≥ 1/3 SD, the risk of EPL increased by 36% (OR [95%CI]=1.36 [1.09, 1.70], P=0.006). Subgroup analyses supported the robustness of these results. Conclusion: PDT ≥ 1/5 SD, 1/3 SD, and 1/2 SD are significantly associated with an increased risk of EPL. This suggests that these thresholds hold potential predictive value in EPL diagnosis and may help identify pregnant women at higher risk for early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.